Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 102.43% vs -16.90% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is 478.95% vs 375.00% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is 120.00% vs 26.44% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 14.29% vs 4.26% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025
Compare Quarterly Results Of Concord Drugs With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is -0.67% vs -44.72% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 102.43% vs -16.90% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is -0.90% vs 109.43% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 478.95% vs 375.00% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 5.68% vs 53.69% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 120.00% vs 26.44% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 40.00% vs 0.00% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 14.29% vs 4.26% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025